Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
75.58
-0.16 (-0.21%)
Mar 9, 2026, 2:34 PM EDT - Market open
Hologic Revenue
Hologic had revenue of $1.05B in the quarter ending December 27, 2025, with 2.54% growth. This brings the company's revenue in the last twelve months to $4.13B, up 2.17% year-over-year. In the fiscal year ending September 27, 2025, Hologic had annual revenue of $4.10B with 1.74% growth.
Revenue (ttm)
$4.13B
Revenue Growth
+2.17%
P/S Ratio
4.09
Revenue / Employee
$583,663
Employees
7,070
Market Cap
16.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 27, 2025 | 4.10B | 70.20M | 1.74% |
| Sep 28, 2024 | 4.03B | -100.00K | -0.00% |
| Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
| Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
| Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
| Sep 26, 2020 | Pro | Pro | Pro |
| Sep 28, 2019 | Pro | Pro | Pro |
| Sep 29, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 24, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Becton, Dickinson and Company | 21.92B |
| Baxter International | 11.24B |
| Alcon | 10.40B |
| Solventum | 8.33B |
| ResMed | 5.40B |
| Bausch + Lomb | 5.10B |
| The Cooper Companies | 4.15B |
| Align Technology | 4.03B |
HOLX News
- 4 weeks ago - Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio - Business Wire
- 5 weeks ago - Hologic Announces Financial Results for First Quarter of Fiscal 2026 - Business Wire
- 7 weeks ago - Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - Business Wire
- 7 weeks ago - Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening - Business Wire
- 2 months ago - Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams - Business Wire
- 3 months ago - New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration - Business Wire
- 3 months ago - New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA - Business Wire
- 4 months ago - Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking - Business Wire